Cargando…
Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel
Ticagrelor (TIC), a P2Y purinoceptor 12 (P2Y(12))-receptor antagonist, has been widely used to treat patients with acute coronary syndrome. Although animal studies suggest that TIC protects against atherosclerosis, it remains unknown whether it does so through its potent platelet inhibition or throu...
Autores principales: | Halim, Hasseri, Pinkaew, Decha, Chunhacha, Preedakorn, Sinthujaroen, Patuma, Thiagarajan, Perumal, Fujise, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594647/ https://www.ncbi.nlm.nih.gov/pubmed/31242230 http://dx.doi.org/10.1371/journal.pone.0218934 |
Ejemplares similares
-
Fortilin inhibits p53, halts cardiomyocyte apoptosis, and protects the heart against heart failure
por: Chunhacha, Preedakorn, et al.
Publicado: (2021) -
Fortilin binds IRE1α and prevents ER stress from signaling apoptotic cell death
por: Pinkaew, Decha, et al.
Publicado: (2017) -
Elevation of serum fortilin levels is specific for apoptosis and signifies cell death in vivo
por: Sinthujaroen, Patuma, et al.
Publicado: (2014) -
GRP78/BiP determines senescence evasion cell fate after cisplatin-based chemotherapy
por: Ei, Zin Zin, et al.
Publicado: (2021) -
Serum paraoxonase 1 (PON1) measurement: an update
por: Ceron, Jose J, et al.
Publicado: (2014)